Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism-Reference-Cited by-同舟云学术

Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism

Published:2017-10 Issue:5 Volume:56 Page:691-693
ISSN:1028-4559
Container-title:Taiwanese Journal of Obstetrics and Gynecology
language:en
Short-container-title:Taiwanese Journal of Obstetrics and Gynecology

Author:

Chen Chih-Ping,Tsai Chris,Lin Ming-Huei,Chern Schu-Rern,Chen Shin-Wen,Lai Shih-Ting,Chen Wen-Lin,Pan Chen-Wen,Wang Wayseen

Funder

Ministry of Science and Technology

MacKay Memorial Hospital, Taipei, Taiwan

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference17 articles.

1. Spontaneous abortion and confined chromosomal mosaicism;Kalousek;Hum Genet,1992

2. Confined placental mosaicism;Simoni;Prenat Diagn,1994

3. Clinical and molecular studies in full trisomy 22: further delineation of the phenotype and review of the literature;Bacino;Am J Med Genet,1995

4. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing;Liang;Prenat Diagn,2013

5. Noninvasive prenatal testing for whole fetal chromosomal aneuploidies: a multicenter prospective cohort trial in Taiwan;Shaw;Fetal Diagn Ther,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, Prevention, and Management of Fetal Growth Restriction (FGR);Journal of Personalized Medicine;2024-06-28

2. Trisomy 22: First and Second Trimester Cytogenetic Analysis and Phenotypic Presentation in a Series of Seven Cases;Fetal Diagnosis and Therapy;2023-11-03

3. Systematic analysis of the causes of NIPS sex chromosome aneuploidy false‐positive results;Molecular Genetics & Genomic Medicine;2022-05-10

4. Chromosomal Microarray Analysis Compared With Noninvasive Prenatal Testing in Pregnancies With Abnormal Maternal Serum Screening;Obstetrics & Gynecology;2022-04-05

5. Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening–detectable findings;American Journal of Obstetrics and Gynecology;2021-11